Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BOLLARD, Catherine M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 30

  • Page / 2
Export

Selection :

  • and

Gene-marking studies of hematopoietic cellsBOLLARD, Catherine M; HESLOP, Helen E; BRENNER, Malcolm K et al.International journal of hematology. 2001, Vol 73, Num 1, pp 14-22, issn 0925-5710Article

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapyROSSIG, Claudia; BOLLARD, Catherine M; NUCHTERN, Jed G et al.Blood. 2002, Vol 99, Num 6, pp 2009-2016, issn 0006-4971Article

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative diseaseBOLLARD, Catherine M; SAVOLDO, Barbara; ROONEY, Cliona M et al.Acta haematologica. 2003, Vol 110, Num 2-3, pp 139-148, issn 0001-5792, 10 p.Article

Targeting of GD2-POSITIVE tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genesROSSIG, Claudia; BOLLARD, Catherine M; NUCHTERN, Jed G et al.International journal of cancer. 2001, Vol 94, Num 2, pp 228-236, issn 0020-7136Article

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane ProteinsBOLLARD, Catherine M; GOTTSCHALK, Stephen; PRO, Barbara et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 798-808, issn 0732-183X, 11 p.Article

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationLEEN, Ann M; CHRISTIN, Anne; BRENNER, Malcolm K et al.Blood. 2009, Vol 114, Num 19, pp 4283-4292, issn 0006-4971, 10 p.Article

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsLOUIS, Chrystal U; STRAATHOF, Karin; ROONEY, Cliona M et al.Blood. 2009, Vol 113, Num 11, pp 2442-2450, issn 0006-4971, 9 p.Article

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of GlioblastomaGHAZI, Alexia; ASHOORI, Aidin; HEGDE, Meenakshi et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 159-168, issn 1524-9557, 10 p.Article

Lovastatin Inhibits T-cell Proliferation While Preserving the Cytolytic Function of EBV, CMV, and MART-1-specific CTLsDAN LI; YUFENG LI; HWU, Patrick et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 9, pp 975-982, issn 1524-9557, 8 p.Article

A novel latent membrane 2 transcript expressed in Epstein-Barr virus―positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapyFOX, Christopher P; HAIGH, Tracey A; RICKINSON, Alan B et al.Blood. 2010, Vol 116, Num 19, pp 3695-3704, issn 0006-4971, 10 p.Article

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsMELENHORST, J. Joseph; LEEN, Ann M; BOLLARD, Catherine M et al.Blood. 2010, Vol 116, Num 22, pp 4700-4702, issn 0006-4971, 3 p.Article

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesHANLEY, Patrick J; YOUNG CRUZ, Conrad Russell; ROONEY, Cliona M et al.Blood. 2009, Vol 114, Num 9, pp 1958-1967, issn 0006-4971, 10 p.Article

Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β ReceptorFOSTER, Aaron E; DOTTI, Gianpietro; AN LU et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 5, pp 500-505, issn 1524-9557, 6 p.Article

Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-β receptorLACUESTA, Kristine; BUZA, Elizabeth; HESLOP, Helen E et al.Journal of immunotherapy (1997). 2006, Vol 29, Num 3, pp 250-260, issn 1524-9557, 11 p.Article

Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia―Implications for ImmunotherapyWEBER, Gerrit; CARUANA, Ignazio; ROUCE, Rayne H et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5079-5091, issn 1078-0432, 13 p.Article

Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4CRUZ, Conrad R; GERDEMANN, Ulrike; ROONEY, Cliona M et al.Clinical cancer research (Print). 2011, Vol 17, Num 22, pp 7058-7066, issn 1078-0432, 9 p.Article

Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal CarcinomaLOUIS, Chrystal U; STRAATHOF, Karin; GEE, Adrian et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 9, pp 983-990, issn 1524-9557, 8 p.Article

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic ActivityKENNEDY-NASSER, Alana A; KU, Stephanie; SAVOLDO, Barbara et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2215-2225, issn 1078-0432, 11 p.Article

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesCOHEN, Jeffrey I; JAFFE, Elaine S; BURBELO, Peter D et al.Blood. 2011, Vol 117, Num 22, pp 5835-5849, issn 0006-4971, 15 p.Article

Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo ExpansionDONGXIA XING; RAMSAY, Alan G; SHAH, Nina et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 7, pp 684-696, issn 1524-9557, 13 p.Article

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipientsHESLOP, Helen E; SLOBOD, Karen S; AMROLIA, Persis J et al.Blood. 2010, Vol 115, Num 5, pp 925-935, issn 0006-4971, 11 p.Article

Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes : Potential for Immunotherapy of CancerLANDMEIER, Silke; ALTVATER, Bianca; PSCHERER, Sibylle et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 3, pp 310-321, issn 1524-9557, 12 p.Article

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBOLLARD, Catherine M; GOTTSCHALK, Stephen; GRESIK, M. Victoria et al.Blood. 2007, Vol 110, Num 8, pp 2838-2845, issn 0006-4971, 8 p.Article

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin diseaseBOLLARD, Catherine M; STRAATHOF, Karin C. M; HULS, M. Helen et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 4, pp 317-327, issn 1524-9557, 11 p.Article

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationMICKLETHWAITE, Kenneth P; SAVOLDO, Barbara; HESLOP, Helen E et al.Blood. 2010, Vol 115, Num 13, pp 2695-2703, issn 0006-4971, 9 p.Article

  • Page / 2